M02.3 Reiter's disease

Name of the Condition

• Reiter's disease (ICD Code: M02.3)

Summary

Reiter's disease is a form of reactive arthritis characterized by joint inflammation, often following an infection. The condition typically involves pain, swelling, and stiffness in the joints, commonly affecting the knees, ankles, or feet. Symptoms may also include extra-articular manifestations such as eye inflammation, skin rashes, or urinary tract issues. It is considered a post-infectious complication linked to immune responses triggered by the initial infection.

Causes

Reiter's disease is caused by the body's immune response to infections, most commonly bacterial infections of the genitourinary or gastrointestinal tract. The infection triggers an inflammatory reaction that can affect joints, even after the initial infection has resolved. The exact mechanism involves immune complex formation and systemic inflammation, though the precise pathways are not fully understood.

Risk Factors

• History of genitourinary or gastrointestinal infections, such as Chlamydia trachomatis or Salmonella.
• Pre-existing joint conditions or autoimmune tendencies.
• Genetic predisposition to inflammatory arthritis.
• Delayed or inadequate treatment of the initial infection.

Symptoms

• Joint pain, swelling, and stiffness, often affecting the knees, ankles, or feet.
• Eye inflammation (conjunctivitis or uveitis).
• Skin rashes or lesions, such as keratoderma blennorrhagicum.
• Urinary tract symptoms, including pain or discharge.
• Symptoms typically develop weeks to months after the initial infection.

Diagnosis

Diagnosis involves a clinical evaluation of symptoms, including joint inflammation and extra-articular manifestations, combined with a history of recent infection. Laboratory tests may include screening for infectious agents, inflammatory markers, and imaging studies to assess joint involvement. The diagnosis is based on the characteristic triad of arthritis, urethritis, and conjunctivitis, though not all features may be present.

Treatment Options

• Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation.
• Antibiotics if a bacterial infection is identified as the trigger.
• Physical therapy to maintain joint function and mobility.
• Corticosteroids or disease-modifying antirheumatic drugs (DMARDs) for severe cases.
• Management of extra-articular symptoms, such as eye drops for conjunctivitis.

Prognosis and Follow-Up

Most patients experience improvement within weeks to months, though some may have recurrent episodes or chronic joint symptoms. Follow-up care focuses on monitoring for complications, managing symptoms, and addressing any persistent inflammation. Long-term outcomes depend on the severity of joint involvement and response to treatment.

Complications

• Chronic arthritis with joint damage.
• Recurrent infections or relapses.
• Eye complications, such as uveitis, which may lead to vision impairment.
• Cardiovascular or other systemic manifestations in rare cases.

Lifestyle & Prevention

• Prompt treatment of genitourinary or gastrointestinal infections to reduce risk.
• Safe sexual practices to prevent sexually transmitted infections.
• Regular exercise to maintain joint flexibility and strength.
• Avoiding triggers, such as reinfection or stress, that may exacerbate symptoms.

When to Seek Professional Help

Seek medical attention if joint pain, swelling, or stiffness persists or worsens, or if extra-articular symptoms like eye pain, skin rashes, or urinary issues develop. Immediate care is needed for severe symptoms, such as vision changes or difficulty moving joints.

Tips for Medical Coders

Document the presence of reactive arthritis following an infection, including the type of infection (genitourinary or gastrointestinal) if known. Ensure the code M02.3 is used only when the condition is clearly linked to a preceding infection and not due to other causes. Include details of extra-articular manifestations (e.g., conjunctivitis, urethritis) to support the diagnosis.